Biden’s New Medicine Rules Have Pharmaceutical Companies Slow-Walking New Therapies Robert Schmad on December 22, 2023 Pharmaceutical companies are delaying, or outright canceling, the development of new medicines following new …
Topic:
therapies
-
-
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive disorders to …
-
(Reuters) -The U.S. Food and Drug Administration is moving to optimize the development of gene therapies, including encouraging the use of biomarkers to help get accelerated approval of therapies for …
-
By Julie Steenhuysen CHICAGO (Reuters) -The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated …